<p>AdaptHealth Corp.（纳斯达克代码：AHCO - 获取免费报告）在周一的午盘交易中，股价创下 52 周新低。该股最低交易价为 7.40 美元，最后交易价为 7.59 美元，成交量为 824 股。该股此前收盘价为 7.79 美元。</p>
<h2>分析师评级调整</h2>
<ul>
<li>3 只小型股领军者有望实现显著增长</li>
</ul>
<p>多家股票分析师对 AHCO 股票发布了报告。瑞银集团将 AdaptHealth 的目标价从 12.00 美元下调至 11.00 美元，并在 2 月 13 日的报告中给予该公司 “买入” 评级。加拿大皇家银行将 AdaptHealth 的目标价从 11.00 美元上调至 14.00 美元，并在 2 月 26 日的报告中给予该股 “跑赢大盘” 评级。Canaccord Genuity Group 将 AdaptHealth 的目标价从 13.00 美元上调至 14.00 美元，并在 2 月 26 日的研究报告中给予该股 “买入” 评级。罗伯特·W·贝尔德将 AdaptHealth 的目标价从 14.00 美元上调至 16.00 美元，并在 2 月 27 日的研究报告中给予该公司 “跑赢大盘” 评级。最后，Truist Financial 将 AdaptHealth 的目标价从 12.00 美元上调至 14.00 美元，并在 2 月 26 日的报告中给予该公司 “买入” 评级。五位研究分析师对该股给予了 “买入” 评级，根据 MarketBeat.com 的数据，AdaptHealth 目前的平均评级为 “买入”，平均目标价为 13.80 美元。</p>
<p><strong>查看我们关于 AdaptHealth 的最新报告</strong></p>
<h2>AdaptHealth 股票表现</h2>
<p>该公司的市值为 10.2 亿美元，市盈率为-4.59，PEG 比率为 1.08，贝塔值为 1.44。该公司的 50 日简单移动平均线为 9.70 美元，200 日简单移动平均线为 9.96 美元。该公司的流动比率为 1.24，速动比率为 1.00，债务与股本比率为 1.34。</p>
<h2>AdaptHealth 的机构交易</h2>
<p>多家机构投资者和对冲基金最近买入和卖出了该股票的股份。Assetmark Inc.在第四季度新购入了价值约 28,000 美元的 AdaptHealth 股份。Blue Trust Inc.在第四季度将其在 AdaptHealth 的持股比例提高了 24.1%。Blue Trust Inc.目前拥有 5,746 股该公司的股票，价值 55,000 美元，此前在上个季度增持了 1,115 股。GAMMA Investing LLC 在第一季度将其在 AdaptHealth 的持股比例提高了 175.2%。GAMMA Investing LLC 目前拥有 7,473 股该公司的股票，价值 81,000 美元，此前在此期间增持了 4,758 股。Empirical Financial Services LLC（以 Empirical Wealth Management 名义运营）在第四季度将其在 AdaptHealth 的持股比例提高了 15.4%。Empirical Financial Services LLC 目前拥有 12,663 股该公司的股票，价值 121,000 美元，此前在上个季度增持了 1,690 股。最后，Guggenheim Capital LLC 在第四季度将其在 AdaptHealth 的持股比例提高了 10.1%。Guggenheim Capital LLC 目前拥有 16,613 股该公司的股票，价值 158,000 美元，此前在上个季度增持了 1,525 股。82.67% 的股票目前由机构投资者持有。</p>
<h2>AdaptHealth 公司简介</h2>
<p>（获取免费报告）</p>
<p>AdaptHealth Corp.及其子公司在美国销售家庭医疗设备（HME）、医疗用品以及家庭和相关服务。该公司提供睡眠治疗设备、用品及相关服务，如为患有阻塞性睡眠呼吸暂停的个人提供 CPAP 和 bi-PAP 服务；医疗设备和用品，包括用于糖尿病治疗的连续血糖监测仪和胰岛素泵；向从急性护理和其他设施出院的患者提供 HME；在家中提供氧气和相关慢性治疗服务；以及代表慢性病患者提供伤口护理、泌尿、失禁、造口和营养供应需求的其他 HME 设备和用品。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们更看好的股票，胜过 AdaptHealth</li>
<li>电话会议与个人投资者</li>
<li>这个波动的市场适合对这些股票进行小额投资</li>
<li>Roth IRA 计算器：计算您的潜在回报</li>
<li>黄金创下历史新高，但这种安静的金属也在上涨</li>
<li>为什么除息日对投资者来说意义重大？</li>
<li>D-Wave Quantum 因芯片新闻下滑：是否是买入机会？</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 AdaptHealth 吗？</h2>
<p>在考虑投资 AdaptHealth 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 AdaptHealth 并不在名单上。</p>
<p>虽然 AdaptHealth 目前在分析师中获得 “买入” 评级，但顶级分析师认为这五只股票更值得投资。</p>
<p>查看这五只股票</p>

AHCO

<p>AdaptHealth Corp.（纳斯达克代码：AHCO）创下了 52 周新低，报 7.40 美元，收盘价为 7.59 美元，交易量为 824 股。分析师的看法不一，瑞银将其目标价从 12.00 美元下调至 11.00 美元，而加拿大皇家银行则将目标价从 11.00 美元上调至 14.00 美元。该股票的平均评级为 “买入”，目标价为 13.80 美元。机构投资者持有该股票的 82.67%，公司专注于家庭医疗设备及相关服务</p>

<p>AdaptHealth Corp. (NASDAQ:AHCO - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $7.40 and last traded at $7.59, with a volume of 824 shares traded. The stock had previously closed at $7.79.</p>
<div class="lb-trans"><p>AdaptHealth Corp.（纳斯达克代码：AHCO - 获取免费报告）在周一的午盘交易中，股价创下 52 周新低。该股最低交易价为 7.40 美元，最后交易价为 7.59 美元，成交量为 824 股。该股此前收盘价为 7.79 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级调整</h2>
</div><ul>
<li>3 Small-Cap Leaders Poised for Significant Growth</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只小型股领军者有望实现显著增长</li>
</ul>
</div><p>A number of equities analysts have issued reports on AHCO shares. UBS Group decreased their price objective on AdaptHealth from $12.00 to $11.00 and set a &#34;buy&#34; rating for the company in a report on Thursday, February 13th. Royal Bank of Canada upped their price objective on shares of AdaptHealth from $11.00 to $14.00 and gave the stock an &#34;outperform&#34; rating in a report on Wednesday, February 26th. Canaccord Genuity Group boosted their price target on AdaptHealth from $13.00 to $14.00 and gave the stock a &#34;buy&#34; rating in a research report on Wednesday, February 26th. Robert W. Baird lifted their price objective on AdaptHealth from $14.00 to $16.00 and gave the company an &#34;outperform&#34; rating in a research note on Thursday, February 27th. Finally, Truist Financial raised their price target on AdaptHealth from $12.00 to $14.00 and gave the company a &#34;buy&#34; rating in a report on Wednesday, February 26th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, AdaptHealth presently has an average rating of &#34;Buy&#34; and an average target price of $13.80.</p>
<div class="lb-trans"><p>多家股票分析师对 AHCO 股票发布了报告。瑞银集团将 AdaptHealth 的目标价从 12.00 美元下调至 11.00 美元，并在 2 月 13 日的报告中给予该公司 “买入” 评级。加拿大皇家银行将 AdaptHealth 的目标价从 11.00 美元上调至 14.00 美元，并在 2 月 26 日的报告中给予该股 “跑赢大盘” 评级。Canaccord Genuity Group 将 AdaptHealth 的目标价从 13.00 美元上调至 14.00 美元，并在 2 月 26 日的研究报告中给予该股 “买入” 评级。罗伯特·W·贝尔德将 AdaptHealth 的目标价从 14.00 美元上调至 16.00 美元，并在 2 月 27 日的研究报告中给予该公司 “跑赢大盘” 评级。最后，Truist Financial 将 AdaptHealth 的目标价从 12.00 美元上调至 14.00 美元，并在 2 月 26 日的报告中给予该公司 “买入” 评级。五位研究分析师对该股给予了 “买入” 评级，根据 MarketBeat.com 的数据，AdaptHealth 目前的平均评级为 “买入”，平均目标价为 13.80 美元。</p>
</div><p><strong>View Our Latest Report on AdaptHealth</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 AdaptHealth 的最新报告</strong></p>
</div><h2>AdaptHealth Stock Performance</h2>
<div class="lb-trans"><h2>AdaptHealth 股票表现</h2>
</div><p>The company has a market cap of $1.02 billion, a P/E ratio of -4.59, a PEG ratio of 1.08 and a beta of 1.44. The business's 50 day simple moving average is $9.70 and its 200 day simple moving average is $9.96. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34.</p>
<div class="lb-trans"><p>该公司的市值为 10.2 亿美元，市盈率为-4.59，PEG 比率为 1.08，贝塔值为 1.44。该公司的 50 日简单移动平均线为 9.70 美元，200 日简单移动平均线为 9.96 美元。该公司的流动比率为 1.24，速动比率为 1.00，债务与股本比率为 1.34。</p>
</div><h2>Institutional Trading of AdaptHealth</h2>
<div class="lb-trans"><h2>AdaptHealth 的机构交易</h2>
</div><p>A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Assetmark Inc. bought a new position in shares of AdaptHealth during the 4th quarter valued at approximately $28,000. Blue Trust Inc. raised its stake in shares of AdaptHealth by 24.1% during the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock valued at $55,000 after acquiring an additional 1,115 shares in the last quarter. GAMMA Investing LLC lifted its holdings in shares of AdaptHealth by 175.2% in the 1st quarter. GAMMA Investing LLC now owns 7,473 shares of the company's stock worth $81,000 after buying an additional 4,758 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its holdings in AdaptHealth by 15.4% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company's stock worth $121,000 after acquiring an additional 1,690 shares in the last quarter. Finally, Guggenheim Capital LLC boosted its stake in shares of AdaptHealth by 10.1% during the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock valued at $158,000 after purchasing an additional 1,525 shares in the last quarter. 82.67% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>多家机构投资者和对冲基金最近买入和卖出了该股票的股份。Assetmark Inc.在第四季度新购入了价值约 28,000 美元的 AdaptHealth 股份。Blue Trust Inc.在第四季度将其在 AdaptHealth 的持股比例提高了 24.1%。Blue Trust Inc.目前拥有 5,746 股该公司的股票，价值 55,000 美元，此前在上个季度增持了 1,115 股。GAMMA Investing LLC 在第一季度将其在 AdaptHealth 的持股比例提高了 175.2%。GAMMA Investing LLC 目前拥有 7,473 股该公司的股票，价值 81,000 美元，此前在此期间增持了 4,758 股。Empirical Financial Services LLC（以 Empirical Wealth Management 名义运营）在第四季度将其在 AdaptHealth 的持股比例提高了 15.4%。Empirical Financial Services LLC 目前拥有 12,663 股该公司的股票，价值 121,000 美元，此前在上个季度增持了 1,690 股。最后，Guggenheim Capital LLC 在第四季度将其在 AdaptHealth 的持股比例提高了 10.1%。Guggenheim Capital LLC 目前拥有 16,613 股该公司的股票，价值 158,000 美元，此前在上个季度增持了 1,525 股。82.67% 的股票目前由机构投资者持有。</p>
</div><h2>AdaptHealth Company Profile</h2>
<div class="lb-trans"><h2>AdaptHealth 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.</p>
<div class="lb-trans"><p>AdaptHealth Corp.及其子公司在美国销售家庭医疗设备（HME）、医疗用品以及家庭和相关服务。该公司提供睡眠治疗设备、用品及相关服务，如为患有阻塞性睡眠呼吸暂停的个人提供 CPAP 和 bi-PAP 服务；医疗设备和用品，包括用于糖尿病治疗的连续血糖监测仪和胰岛素泵；向从急性护理和其他设施出院的患者提供 HME；在家中提供氧气和相关慢性治疗服务；以及代表慢性病患者提供伤口护理、泌尿、失禁、造口和营养供应需求的其他 HME 设备和用品。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than AdaptHealth</li>
<li>Conference Calls and Individual Investors</li>
<li>This Volatile Market Is Made For Nickel-and-Diming These Names</li>
<li>Roth IRA Calculator: Calculate Your Potential Returns</li>
<li>Gold Is Making All-Time Highs, But So Is This Quiet Metal</li>
<li>Why is the Ex-Dividend Date Significant to Investors?</li>
<li>D-Wave Quantum Slides on Chip News: Opportunity to Buy?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 AdaptHealth</li>
<li>电话会议与个人投资者</li>
<li>这个波动的市场适合对这些股票进行小额投资</li>
<li>Roth IRA 计算器：计算您的潜在回报</li>
<li>黄金创下历史新高，但这种安静的金属也在上涨</li>
<li>为什么除息日对投资者来说意义重大？</li>
<li>D-Wave Quantum 因芯片新闻下滑：是否是买入机会？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in AdaptHealth Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 AdaptHealth 吗？</h2>
</div><p>Before you consider AdaptHealth, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑投资 AdaptHealth 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdaptHealth wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 AdaptHealth 并不在名单上。</p>
</div><p>While AdaptHealth currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 AdaptHealth 目前在分析师中获得 “买入” 评级，但顶级分析师认为这五只股票更值得投资。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

AdaptHealth（纳斯达克股票代码：AHCO）创下 12 个月新低 - 以下是原因